Therapeutic use of the Dialysis Prescription for Improvement in Blood Pressure Control

US Renal Data System: USRDS 2001 Annual Data Report: Atlas of end-stage renal disease in the United States. Bethesda. MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001. Available: http://www.USRDS.org\ADR.HTM.

Fenton S.S.A. , Schaubel D.E. , Desmeules M. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30: 334–42.

Sytkowski P.A. , D'Agostino R.B. , Belanger A.J. , Kannel W.B. . Secular trends in long-term sustained hypertension: Long-term treatment in cardiovascular mortality. The Framingham Heart Study - 1950–1990. Circulation 1996; 193: 697–703.

Charra B. , Calemard E. , Ruffet M. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41: 1286–91.

Pierratos A. . Daily hemodialysis. Curr Opin Nephrol Hypertens 2000; 9: 637–42.

Pierratos A. . Nocturnal home hemodialysis: An update on a five-year experience. Nephrol Dial Transplant 1999; 14: 2835–40.

Buoncristiani U. , Fagugli R.M. , Pinciaroli M.R. , Kulurianu H. , Ceravolo G. , Bova C. . Reversal of left ventricular hypertrophy in uremic patients by treatment with daily hemodialysis. Contrib Nephrol 1996; 119: 152–8.

Traeger J. , Sibai-galiand R. , Delawari E. , Arkouche W. . Daily versus standard hemodialysis: One-year experience. Artif Organs 1998; 22: 558–63.

Galland R. , Traeger J. , Delawari E. Control of hypertension and regression of left ventricular hypertrophy by daily hemodialysis. J Am Soc Nephrol 1999; 10: 279a.

Katzarski K.S. , Charra B. , Luik A.J. Fluid state and blood pressure in patients treated with long and short hemodialysis. Nephrol Dial Transplant 1999; 14: 369–75.

Zager P.G. , Nikolic J. , Brown R.H. , Teredesai P. . “U”curve association of blood pressure and mortality in hemodialysis. Kidney Int 1998; 54: 561–9.

Port F.K. , Hulbert-Shearon T.E. , Wolfe R.A. Pre-dialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999; 33: 507–17.

Salem M.M. . Hypertension in the hemodialysis population: Any relationship to two-year survival? Nephrol Dial Transplant 1999; 14: 125–8.

Salem M.M. , Bower J. . Hypertension in the hemodialysis population: Any relation to one-year survival? Am J Kidney Dis 1996; 28: 737–40.

Klassen P.S. , Lowrie E.G. , Reddan D.N. Association between pulse pressure and mortality in maintenance hemodialysis patients. (Submitted) JAMA.

Henderson L.W. . Of time, TACurea and treatment schedules. Kidney Int 1988; 33(Suppl 22): S105–6.

Henderson L.W. , Clark W. . Modeling and the middle molecule. (Editorial) Semin Dial 1998; 11: 228–30.

Clark W.R. , Leypoldt J.K. , Henderson L.W. , Mueller B.A. , Scott M.K. , Vonesh E.F. . Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model. J Am Soc Nephrol 1999; 10: 601–9.

Quellhorst E.A. . Blood pressure control in hemofiltration. In: Hemofiltration, Henderson LW , Quellhorst EA , Baldamus CA , Lysaght MJ (eds), Springer-Verlag, pp. 202–8, 1986.

Altieri P. , Sorba G. , Bolasco P. Pre-dilution hemofiltration-The Second Sardinian Multicenter Study: Comparison between hemofiltration and hemodialysis during identical KT/V and session times in a long-term crossover study. Nephrol Dial Transplant 2001; 16: 1207–13.

Nolph K.D. , Hano J.E. , Teschan P.E. . Peritoneal sodium transport during hypertonic peritoneal dialysis. Physiologic Mechanisms and Clinical implications. Ann Intern Med 1969; 70: 931–41.

Krediet R.T. , Ho-dac-Pannekeet M.M. , Imholz A.L.T. , Struijk D.G. . Icodextrins effects on peritoneal transport. Perit Dial Int 1997; 17: 35–41.

Woodrow G. , Oldroyds B. , Stables G. , Gibson J. , Turney J.H.B. . Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectric impedence analysis. Nephrol Dial Transplant 2000; 15: 862–6.